Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- Check6 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov error page's footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site’s displayed revision changes from v3.7.0 to v3.7.1, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the detailed study record content with a minimal error screen.SummaryDifference18%

- Check62 days agoChange DetectedThe page now shows a revised version tag updating from v3.6.5 to v3.6.6, reflecting a small internal update rather than any change to study content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe Study Details page now includes a Study Documents section with PDF links for the Study Protocol and Statistical Analysis Plan and related MeSH terms, expanding access to the study’s documentation and terminology. This change replaces the prior error content, restoring full resources on the page.SummaryDifference100%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.